MedTrace Logo

EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)

NCT03569722 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2019-02-04

No results posted yet for this study

Summary

EpxCogScreen is a phone-based intervention to administer the Rapid Cognitive Screen, a validated screening tool for dementia, over SMS text messaging. The results of the screen are sent to the physician automatically, which allows physicians to monitor their patients and gives them the ability to respond rapidly to any concerns of cognitive decline. In this study, patients' at-home RCS scores done by EpxCogScreen will be compared to their in-clinic RCS scores, and to clinical diagnosis of dementia (where available), to investigate the validity of EpxCogScreen.

Conditions

  • Dementia
  • Telemedicine
  • Cognitive Dysfunction

Sponsors & Collaborators

  • Theodore Malmstrom, PhD

    lead OTHER

Principal Investigators

  • Theodore K Malmstrom, PhD · Saint Louis Univeristy

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-21
Primary Completion
2019-01-02
Completion
2019-01-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03569722 on ClinicalTrials.gov